Infectious complications (all types of bacterial, viral, and fungal infections except for SARS-CoV-2 infections) during AML therapy were observed more frequently in TLR3 rs5743305 AA homozygotes (p = 0.015), Figure 4. This evidence concerns the gene TLR3 and acute myeloid leukemia.